Home » Topics » BioWorld Science

BioWorld Science
RSS

Regulus Therapeutics announces corporate restructuring

July 6, 2018

MHRA approves Xonvea in U.K. for nausea and vomiting of pregnancy

July 6, 2018

Topline results from final analysis of phase II trial of BAN-2401 in Alzheimer's

July 6, 2018

Herantis initiates development program for noninvasive CDNF

July 6, 2018

Medshine Discovery and collaborator patent CCR-2 and CCR-5 antagonists

July 6, 2018

Zydus Cadila and CSIR-IMTECH collaborate to tackle drug-resistant infections

July 6, 2018

Nanjing TransThera Biosciences synthesizes protein kinase inhibitors for cancer

July 6, 2018

Icahn School of Medicine at Mount Sinai discloses PROTAc compounds for cancer

July 6, 2018

EMA validates Clovis' application for Rubraca as maintenance treatment for recurrent ovarian cancer

July 6, 2018

Boehringer Ingelheim divulges SLC13A5 inhibitors

July 6, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...